Navigation Links
Globus Medical's MicroFuse(TM) Technology Engineered for Optimal Strength and Porosity
Date:3/25/2009

AUDUBON, Pa., March 25 /PRNewswire/ -- Globus Medical, Inc., the largest privately held spinal implant manufacturer in the world, today announced the launch of MicroFuse(TM) ST Granules, a unique resorbable polymer bone void filler optimized for both strength and porosity. MicroFuse(TM) technology utilizes proprietary combinations of poly (lactic acid) and poly (lactide-co-glycolide) polymers manufactured with a patented microsphere process to deliver up to twelve times the strength and twice the ideal porosity ratio of competing synthetic bone void fillers.

MicroFuse(TM)'s strength is derived from its unique three-dimensional structure which translates into better intra-operating handling characteristics. Due to its bonded sphere structure, MicroFuse(TM) is less likely to break apart while mixing with bone graft and during impaction at the bone defect site. MicroFuse(TM)'s structure is also designed to maximize the amount of pores in the optimal range for bone formation. Over 88 percent of MicroFuse(TM) pores are in this ideal range while most porous ceramics have many pores that are too small to allow for bone in-growth or are too large, which can slow the bone regeneration process.

"MicroFuse(TM) technology represents a unique entry into the synthetic bone substitute market. With an optimal combination of strength and porosity, MicroFuse(TM) is specifically engineered to resorb and be fully replaced by bone," said Mark Borden, Ph.D., Director of Biomaterials, Globus Medical, Inc. "From the choice of resorbable polymers to the size of the individual microspheres, developmental efforts were focused on providing the best possible environment for bone growth."

MILDER(TM)-the Natural Evolution of Spine Care

The MicroFuse(TM) ST Granules are the product of a significant development effort by Globus, and represent the latest addition to Globus Medical's MILDER(TM) Spine Care portfolio. MILDER(TM) (Minimally Invasive, Less Disruptive, Earlier Recovery) Spine Care encompasses a holistic approach to spine care that integrates minimally invasive surgical techniques with implants, instrumentation, and education designed to lessen the disruption to a patient's anatomic structures and natural range of motion in order to facilitate an earlier, pain-free recovery.

About Globus Medical, Inc.

Globus Medical, Inc., is the largest privately held spinal implant manufacturer in the world and is based in Audubon, Pa. The company was founded in 2003 by an experienced team of spine professionals with a shared vision to create products that enable spine surgeons to promote healing in patients with spinal disorders. Additional information can be accessed at www.globusmedical.com.


'/>"/>
SOURCE Globus Medical, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Globus Medicals SIGNATURE(TM) Spacer Designed for MILDER(TM) TLIF Procedures
2. Globus Medical Strengthens Executive Team with Appointment of CFO
3. Globus Medical Launches NIKO(TM) Corpectomy Spacer System
4. Globus Medical Announces Record Revenue for 2007
5. Hooper Holmes Concludes Sale of Medicals Direct
6. Council for American Medical Innovation Applauds President Obama for Calling for Serious Investments in Science and Technology
7. OBS Medicals Visensia Patient Monitoring Technology Lowers Cost of Medical Malpractice Insurance
8. CareTech Solutions Launches Robust Service Desk Solution to Support Clinical Applications and Technology within Continuum Health Partners Hospitals
9. Top Neurology Programs Control Fever with Arctic Sun Cooling Technology
10. BioHorizons Announces Its 2009 Global Symposium: Bringing Together Top Thought Leaders in the Dental Implant Industry to Provide Insight on Integrating Technology into the Continuum of Care
11. Sentinelle Medical Receives Frost & Sullivan Excellence in Technology Award
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... June 24, 2016 , ... The Pulmonary Hypertension ... that it will receive two significant new grants to support its work to ... its 25th anniversary by recognizing patients, medical professionals and scientists for their work ...
(Date:6/24/2016)... ... ... Comfort Keepers® of San Diego, CA is excited to announce they are ... drive cancer patients to and from their cancer treatments. Comfort Keepers provides quality ... and ongoing independence. Getting to and from medical treatments is one of the ...
(Date:6/24/2016)... ... June 24, 2016 , ... EB ... Decision Making in Emergency Medicine conference in Ponte Vedra Beach, FL. The awards ... in Emergency Medicine Practice and Pediatric Emergency Medicine Practice. , “With ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... the Frederick area economy by obtaining investment capital for emerging technology companies. ... years that have already resulted in more than a million dollars of capital ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... human induced pluripotent stem (iPS) cells and other difficult to transfect cells, announces ... Medium. The PluriQ™ G9™ Gene Editing System is a complete system ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016 Dehaier Medical ... the "Company"), which develops, markets and sells medical devices ... , signed a strategic cooperation agreement with Hongyuan ... "Hongyuan Supply Chain") on June 20, 2016, to develop ... the strategic cooperation agreement, Dehaier will leverage Hongyuan Supply ...
(Date:6/24/2016)... Belgium , June 24, 2016 ... the appointment of Dr. Edward Futcher ... Non-Executive Director, effective June 23, 2016.Dr. Futcher was ... Nominations and Governance Committees.  As a non-executive member ... independent expertise and strategic counsel to VolitionRx in ...
(Date:6/23/2016)... , June 23, 2016 Research ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, ... (Oral, Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is ... a CAGR of 6.1% in the forecast period 2016 ...
Breaking Medicine Technology: